Camelot Portfolios’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
FAM
WCM
CA
AWA
AA
SWM
ERIC
PFGIA
FWP
RFA
Camelot Portfolios's BCAT Position: Q2 2026 in Review
Camelot Portfolios sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q2 2026, closing a stake of 19,500 shares — an estimated $276K sold.
Camelot Portfolios first reported a position in BCAT in Q4 2022 and held it in 14 quarters. The position peaked at $404K in Q2 2023. 12 funds tracked by Wall St. Rank hold BCAT as of Q2 2026.
- Camelot Portfolios reported no remaining BlackRock Capital Allocation Term Trust position as of Q2 2026 after selling out during the quarter.
- Camelot Portfolios sold 19,500 BlackRock Capital Allocation Term Trust shares in Q2 2026, an estimated $276K.
- Camelot Portfolios first reported a position in BlackRock Capital Allocation Term Trust in Q4 2022 and held it in 14 quarters.
- Camelot Portfolios's BlackRock Capital Allocation Term Trust position peaked at $404K in Q2 2023.
- 12 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2026.
Based on Camelot Portfolios's 13F filing for Q2 2026, filed 17 Jul 2026.